Skip to content
Subscriber Only

Novartis Wins Trial Over Jaw Injury Blamed on Drugs

A New Jersey jury ruled that Novartis AG, the Swiss drugmaker, provided adequate warnings about the risk of its bone-strengthening medicines, rejecting a lawsuit by a woman who claimed the drugs destroyed her jaw.

Jane Bessemer, 73, sued Novartis after developing jawbone damage while taking Aredia and Zometa to slow bone loss as she battled breast cancer. Jurors in state court in New Brunswick, New Jersey, deliberated less than three hours today before finding that Novartis provided proper warnings to Bessemer’s doctors about jaw problems linked to Aredia and Zometa.